Michael Valenzuela

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 4

Top Topics

Virtual Reality

Gold Nanoparticles

Mild Cognitive Impairment

Top Venues

The Medical journal of Australia

Neuropsychology, development, and cognition. Section B, Aging, neuropsychology and cognition

Stem cell research & therapy

University of Sydney

University of New South Wales (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Sydney Apr 01 2012 - Mar 18 2020

Australia

Professor of Regenerative Medicine :: Medicine

Education History

University of New South Wales

Australia

PHD :: Psychiatry, Medicine

University of New South Wales

Australia

BSC :: Science

Publications

Princess Neila Litkouhi, Katya T Numbers, Michael Valenzuela, John D Crawford, Ben Chun Pan Lam, Princess Noosha Litkouhi, Perminder Singh Sachdev, Nicole A Kochan, Henry Brodaty
Critical periods for cognitive reserve building activities for late life global cognition and cognitive decline: the Sydney memory and aging cohort study. Neuropsychology, development, and cognition. Section B, Aging, neuropsychology and cognition (2023)
Michael Valenzuela
Comment on NATSEM's report on the economic and societal cost of Alzheimer disease in Australia. The Medical journal of Australia 216 (10) (2022)
Michael Valenzuela, T Duncan, A Abey, A Johnson, C Boulamatsis, M A Dalton, E Jacobson, L Brunel, G Child, D Simpson, M Buckland, A Lowe, J Siette, F Westbrook, P McGreevy
Autologous skin-derived neural precursor cell therapy reverses canine Alzheimer dementia-like syndrome in a proof of concept veterinary trial. Stem cell research & therapy 13 (1) (2022)
Courtney Campbell Walton, Amit Lampit, Christos Boulamatsis, Harry Hallock, Polly Barr, Jeewani Anupama Ginige, Henry Brodaty, Tiffany Chau, Megan Heffernan, Perminder Singh Sachdev, Maria A Fiatarone Singh, Michael Valenzuela
Design and Development of the Brain Training System for the Digital "Maintain Your Brain" Dementia Prevention Trial. JMIR aging 2 (1) (2019)